Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-20-127416
Filing Date
2020-11-19
Accepted
2020-11-19 17:24:02
Documents
6
Effectiveness Date
2020-11-19

Document Format Files

Seq Description Document Type Size
1 S-8 tm2027048-16_s8.htm S-8 79997
2 EXHIBIT 5.1 tm2027048d16_ex5-1.htm EX-5.1 8849
3 EXHIBIT 23.1 tm2027048d16_ex23-1.htm EX-23.1 2361
4 EXHIBIT 99.3 tm2027048d16_ex99-3.htm EX-99.3 221487
5 EXHIBIT 99.6 tm2027048d16_ex99-6.htm EX-99.6 99944
6 GRAPHIC tm2027048d16_ex5-1img001.jpg GRAPHIC 2535
  Complete submission text file 0001104659-20-127416.txt   417292
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-250209 | Film No.: 201329681
SIC: 2834 Pharmaceutical Preparations